Adição na publicação
#15.35
08/24/2021
RPI 2642
Application data
Number
112018013852Type
Filing
Publication
PCT
US2017012487 The application was abandoned for failure to pay the annuities (art. 86 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 08/24/2021. We update with every new RPI gazette, published weekly.
Applicants
LA JOLLA PHARMACEUTICAL COMPANY
US
Inventors
L. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/276,164 · 01/07/2016
US
62/347,259 · 06/08/2016
Abstract
A presente invenção refere-se à utilização de angiotensinogênio, angiotensina I, angiotensina II, angiotensina III, e/ou angiotensina IV em métodos terapêuticos para o tratamento de hipotensão, tal como hipotensão resistente a catecolaminas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
08/24/2021
RPI 2642
#8.11
Referente ao despacho 8.6 publicado na RPI 2555 de 24/12/2019.
07/07/2020
RPI 2583
#8.6
Referente à 3ª anuidade.
12/24/2019
RPI 2555
#1.3
12/18/2018
RPI 2502
#1.1
07/17/2018
RPI 2480
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.